Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : ZD Inc., Ziff-Davis (ZD) -- Ignore unavailable to you. Want to Upgrade?

To: nestegg who wrote (477)	3/12/1999 9:31:00 PM
From: Maverick	Read Replies (1) \| Respond to of 855

This article shows how powerful GS is in underwriting & upgrading HLTH As noted here Wednesday, Goldman Sachs & Co. was the only underwriter of Healtheon Corp.'s (Nasdaq, HLTH) February initial public offering not to begin recommending Healtheon's shares at the beginning of week. Monday was the 26th day after Healtheon's IPO became effective, the first day analysts who work for the underwriter are allowed to publish their research. Stephen Savas, Goldman's health care information technology analyst, piped up Wednesday with a ''market outperformer'' rating, the brokerage's second-highest. ''First-mover advantage in an industry has given Healtheon a valuation that should allow it to consolidate a fragmented emerging market,'' he told clients. Translation: Expect Healtheon, which is peddling a way to connect health care players on the Internet, to use its inflated stock to acquire numerous competitors. Investors responded exuberantly to Goldman's enthusiasm. The stock rose 62 percent Wednesday to $48.50 a share, giving a market value of $3.3 billion to a company that had 1998 revenues of $48.8 million. The stock fell back 13 percent Thursday to $42.13 a share. Ho-hum. By SJ Mercury News